Skip to main content

Clinical trial BHS-TC14

Allogenic hematopoietic cell transplantation from HLA-matched donor after FLU-Mel-PTCy versus Flu-Mel-ATG reduced intensity conditioning : a phase III randomized study from the Belgian Hematology Society (BHS)

Organ Acute leukemia
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor BHS
EudraCT Identifier 2017-000824-91
Inclusion criteria Hematological malignancies confirmed histologically: - AML in morphological CR or not in morphological CR but not rapidly progressing (i.e. noneed to give treatments such as hydroxyurea to maintain WBC count < 10 000 x109/mL);- MDS;- CML in CP or AP;
Last update